Results for: cancer+drug+revlimid

Costly blood cancer drug gets PBS listing

Cyclacel selling patents to Celgene for $5.5M

Sector Snap: Biotechnology stocks

UK cancer drug fund gets extra 160 million pounds

Celgene 4Q net slumps on charges, higher spending

Stocks surge after Bernanke allays taper fear

No more results returned for this search